BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Is Celgene Brilliant or Downright Crazy?

  July 20, 2015

   · 

  1 min read
• BioCapital

  The Worst Place For Bacteria At The Beach, American Chemical Society Study Reveals

  July 20, 2015

   · 

  1 min read
• 

  Drug Development

  Investors Excited Over Eli Lilly and Biogen’s Upcoming Alzheimer’s Drug Data

  July 20, 2015

   · 

  3 min read
• Pharm Country

  How The New York Times Can Predict Your Future Weight

  July 20, 2015

   · 

  2 min read
• 

  Pharm Country

  Tekmira Changes Name to Arbutus Biopharma, Kills Ebola Program and Focuses on Hepatitis B

  July 20, 2015

   · 

  2 min read
• 

  Drug Development

  Embattled Exelixis Nabs Much-Needed Victory for Phase III Renal Cell Carcinoma Study

  July 20, 2015

   · 

  2 min read
• 

  Drug Development

  Bristol-Myers Squibb’s Opdivo Phase III Study Stopped Early on More Good Cancer Therapy News

  July 20, 2015

   · 

  2 min read
• Deals

  Integra LifeSciences Completes Acquisition Of TEI Biosciences And TEI Medical

  July 20, 2015

   · 

  3 min read
• Deals

  Agenus Bags Novel Antibodies to Immuno-oncology Target for $44 Million+

  July 20, 2015

   · 

  5 min read
• BioCapital

  Fibrocell Science, Inc. And Intrexon Announce IND Filing Of FCX-007 For The Treatment Of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

  July 20, 2015

   · 

  7 min read